The DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
Resistance Development to Bacteriophages Occurring during Bacteriophage Therapy
Open accessAbstract
Bacteriophage (phage) therapy, i.e., the use of viruses that infect bacteria as antimicrobial agents, is a promising alternative to conventional antibiotics. Indeed, resistance to antibiotics has become a major public health problem after decades of extensive usage. However, one of the main questions regarding phage therapy is the possible rapid emergence of phage-resistant bacterial variants, which could impede favourable treatment outcomes. Experimental data has shown that phage-resistant variants occurred in up to 80% of studies targeting the intestinal milieu and 50% of studies using sepsis models. Phage-resistant variants have also been observed in human studies, as described in three out of four clinical trials that recorded the emergence of phage resistance. On the other hand, recent animal studies suggest that bacterial mutations that confer phage-resistance may result in fitness costs in the resistant bacterium, which, in turn, could benefit the host. Thus, phage resistance should not be underestimated and efforts should be made to develop methodologies for monitoring and preventing it. Moreover, understanding and taking advantage of the resistance-induced fitness costs in bacterial pathogens is a potentially promising avenue.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global trends in antimicrobial use in food animals
Van Boeckel, T. P., Brower, C., Gilbert, M., Grenfell, B. T., Levin, S. A., Robinson, T. P., Teillant, A., & Laxminarayan, R. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1503141112 · Cited by 3,973
Mutations of bacteria from virus sensitivity to virus resistance
Luria, S. E., & Delbrück, M. (1943) · Genetics · doi:10.1093/genetics/28.6.491 · Cited by 3,894
Mechanisms of Antibiotic Resistance
Munita, J. M., & Arias, C. A. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.vmbf-0016-2015 · Cited by 2,782
Bacteriophage resistance mechanisms
Labrie, S. J., Samson, J. E., & Moineau, S. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2315 · Cited by 2,397
Lysogenic Conversion by a Filamentous Phage Encoding Cholera Toxin
Waldor, M. K., & Mekalanos, J. J. (1996) · Science · doi:10.1126/science.272.5270.1910 · Cited by 1,879
Lessons from natural molecules
Clardy, J., & Walsh, C. (2004) · Nature · doi:10.1038/nature03194 · Cited by 1,171
Acquired Antibiotic Resistance Genes: An Overview
van Hoek, A. H. A. M., Mevius, D., Guerra, B., Mullany, P., Roberts, A. P., & Aarts, H. J. M. (2011) · Frontiers in Microbiology · doi:10.3389/fmicb.2011.00203 · Cited by 1,136
Beceiro, A., Tomás, M., & Bou, G. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00059-12 · Cited by 1,070
Phage treatment of human infections
Abedon, S. T., Kuhl, S. J., Blasdel, B. G., & Kutter, E. M. (2011) · Bacteriophage · doi:10.4161/bact.1.2.15845 · Cited by 980
Phage Cocktails and the Future of Phage Therapy
Chan, B. K., Abedon, S. T., & Loc-Carrillo, C. (2013) · Future Microbiology · doi:10.2217/fmb.13.47 · Cited by 914
Koskella, B., & Brockhurst, M. A. (2014) · FEMS Microbiology Reviews · doi:10.1111/1574-6976.12072 · Cited by 890
A century of the phage: past, present and future
Salmond, G. P. C., & Fineran, P. C. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3564 · Cited by 823
Host receptors for bacteriophage adsorption
Bertozzi Silva, J., Storms, Z., & Sauvageau, D. (2016) · FEMS Microbiology Letters · doi:10.1093/femsle/fnw002 · Cited by 736
Phage selection restores antibiotic sensitivity in MDR Pseudomonas aeruginosa
Chan, B. K., Sistrom, M., Wertz, J. E., Kortright, K. E., Narayan, D., & Turner, P. E. (2016) · Scientific Reports · doi:10.1038/srep26717 · Cited by 715
A bacteriolytic agent that detects and kills Bacillus anthracis
Schuch, R., Nelson, D., & Fischetti, V. A. (2002) · Nature · doi:10.1038/nature01026 · Cited by 656
Antagonistic coevolution between a bacterium and a bacteriophage
Buckling, A., & Rainey, P. B. (2002) · Proceedings of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rspb.2001.1945 · Cited by 638
Diverse Functions of Restriction-Modification Systems in Addition to Cellular Defense
Vasu, K., & Nagaraja, V. (2013) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00044-12 · Cited by 618
Smith, H. W., & Huggins, M. B. (1982) · Microbiology · doi:10.1099/00221287-128-2-307 · Cited by 518
Rapid Killing of Streptococcus pneumoniae with a Bacteriophage Cell Wall Hydrolase
Loeffler, J. M., Nelson, D., & Fischetti, V. A. (2001) · Science · doi:10.1126/science.1066869 · Cited by 517
Population and evolutionary dynamics of phage therapy
Levin, B. R., & Bull, J. J. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro822 · Cited by 511
Repeatability and Contingency in the Evolution of a Key Innovation in Phage Lambda
Meyer, J. R., Dobias, D. T., Weitz, J. S., Barrick, J. E., Quick, R. T., & Lenski, R. E. (2012) · Science · doi:10.1126/science.1214449 · Cited by 508
Bacteria-Phage Antagonistic Coevolution in Soil
Gómez, P., & Buckling, A. (2011) · Science · doi:10.1126/science.1198767 · Cited by 495
Roach, D. R., Leung, C. Y., Henry, M., Morello, E., Singh, D., Di Santo, J. P., Weitz, J. S., & Debarbieux, L. (2017) · Cell Host & Microbe · doi:10.1016/j.chom.2017.06.018 · Cited by 484
Bacteriophage lysins as effective antibacterials
Fischetti, V. A. (2008) · Current Opinion in Microbiology · doi:10.1016/j.mib.2008.09.012 · Cited by 477
Salmonella enterica: Survival, Colonization, and Virulence Differences among Serovars
Andino, A., & Hanning, I. (2015) · The Scientific World Journal · doi:10.1155/2015/520179 · Cited by 467
Lenski, R. E., & Levin, B. R. (1985) · The American Naturalist · doi:10.1086/284364 · Cited by 460
Evolution of a bacteria/plasmid association
Bouma, J. E., & Lenski, R. E. (1988) · Nature · doi:10.1038/335351a0 · Cited by 446
Smith, H. W., & Huggins, M. B. (1983) · Microbiology · doi:10.1099/00221287-129-8-2659 · Cited by 436
Adaptation to the fitness costs of antibiotic resistance in Escherichia coli
Schrag, S. J., Perrot, V., & Levin, B. R. (1997) · Proceedings of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rspb.1997.0178 · Cited by 396
Clinical Aspects of Phage Therapy
Międzybrodzki, R., Borysowski, J., Weber-Dąbrowska, B., Fortuna, W., Letkiewicz, S., Szufnarowski, K., Pawełczyk, Z., Rogóż, P., Kłak, M., Wojtasik, E., et al. (2012) · Advances in Virus Research · doi:10.1016/b978-0-12-394438-2.00003-7 · Cited by 373
Bacteriophage Therapy To Reduce Campylobacter jejuni Colonization of Broiler Chickens
Loc Carrillo, C., Atterbury, R. J., El-Shibiny, A., Connerton, P. L., Dillon, E., Scott, A., & Connerton, I. F. (2005) · Applied and Environmental Microbiology · doi:10.1128/aem.71.11.6554-6563.2005 · Cited by 367
Faruque, S. M., Naser, I. B., Islam, M. J., Faruque, A. S. G., Ghosh, A. N., Nair, G. B., Sack, D. A., & Mekalanos, J. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408992102 · Cited by 367
The Control of Experimental Escherichia coli Diarrhoea in Calves by Means of Bacteriophages
Smith, H. W., Huggins, M. B., & Shaw, K. M. (1987) · Microbiology · doi:10.1099/00221287-133-5-1111 · Cited by 365
Bacteriophage Therapy To Reduce Salmonella Colonization of Broiler Chickens
Atterbury, R. J., Van Bergen, M. A. P., Ortiz, F., Lovell, M. A., Harris, J. A., De Boer, A., Wagenaar, J. A., Allen, V. M., & Barrow, P. A. (2007) · Applied and Environmental Microbiology · doi:10.1128/aem.00049-07 · Cited by 357
Gnotobiotic mouse model of phage–bacterial host dynamics in the human gut
Reyes, A., Wu, M., McNulty, N. P., Rohwer, F. L., & Gordon, J. I. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1319470110 · Cited by 355 · cited 1×
“analysed the impact of viral predation on a consortium of 14 human bacterial symbionts [65].”
BackgroundThe role of parasites in sympatric and allopatric host diversification
Buckling, A., & Rainey, P. B. (2002) · Nature · doi:10.1038/nature01164 · Cited by 349
Analysis of antibiotic resistance regions in Gram-negative bacteria
Partridge, S. R. (2011) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00277.x · Cited by 344
Harper, D., Parracho, H., Walker, J., Sharp, R., Hughes, G., Werthén, M., Lehman, S., & Morales, S. (2014) · Antibiotics · doi:10.3390/antibiotics3030270 · Cited by 342
Statistical structure of host–phage interactions
Flores, C. O., Meyer, J. R., Valverde, S., Farr, L., & Weitz, J. S. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1101595108 · Cited by 327
Oechslin, F., Piccardi, P., Mancini, S., Gabard, J., Moreillon, P., Entenza, J. M., Resch, G., & Que, Y.-A. (2016) · Journal of Infectious Diseases · doi:10.1093/infdis/jiw632 · Cited by 325
Self-citationCoevolution with viruses drives the evolution of bacterial mutation rates
Pal, C., Maciá, M. D., Oliver, A., Schachar, I., & Buckling, A. (2007) · Nature · doi:10.1038/nature06350 · Cited by 322
Interplay in the Selection of Fluoroquinolone Resistance and Bacterial Fitness
Marcusson, L. L., Frimodt-Møller, N., & Hughes, D. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000541 · Cited by 320
Evolutionary Rationale for Phages as Complements of Antibiotics
Torres-Barceló, C., & Hochberg, M. E. (2016) · Trends in Microbiology · doi:10.1016/j.tim.2015.12.011 · Cited by 308
Hall, A. R., Scanlan, P. D., Morgan, A. D., & Buckling, A. (2011) · Ecology Letters · doi:10.1111/j.1461-0248.2011.01624.x · Cited by 307
The Phage Therapy Paradigm: Prêt-à-Porter or Sur-mesure?
Pirnay, J.-P., De Vos, D., Verbeken, G., Merabishvili, M., Chanishvili, N., Vaneechoutte, M., Zizi, M., Laire, G., Lavigne, R., Huys, I., et al. (2011) · Pharmaceutical Research · doi:10.1007/s11095-010-0313-5 · Cited by 298
Combatting antimicrobial resistance globally
Sugden, R., Kelly, R., & Davies, S. (2016) · Nature Microbiology · doi:10.1038/nmicrobiol.2016.187 · Cited by 278
A Method for Generation Phage Cocktail with Great Therapeutic Potential
Gu, J., Liu, X., Li, Y., Han, W., Lei, L., Yang, Y., Zhao, H., Gao, Y., Song, J., Lu, R., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031698 · Cited by 268
Self-limiting nature of seasonal cholera epidemics: Role of host-mediated amplification of phage
Faruque, S. M., Islam, M. J., Ahmad, Q. S., Faruque, A. S. G., Sack, D. A., Nair, G. B., & Mekalanos, J. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502069102 · Cited by 253
Hanlon, G. W., Denyer, S. P., Olliff, C. J., & Ibrahim, L. J. (2001) · Applied and Environmental Microbiology · doi:10.1128/aem.67.6.2746-2753.2001 · Cited by 244
A cocktail of three virulent bacteriophages prevents Vibrio cholerae infection in animal models
Yen, M., Cairns, L. S., & Camilli, A. (2017) · Nature Communications · doi:10.1038/ncomms14187 · Cited by 237
Toward rational control of Escherichia coli O157:H7 by a phage cocktail
Tanji, Y., Shimada, T., Yoichi, M., Miyanaga, K., Hori, K., & Unno, H. (2004) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-003-1438-9 · Cited by 226
Kamal, F., & Dennis, J. J. (2015) · Applied and Environmental Microbiology · doi:10.1128/aem.02850-14 · Cited by 224
Carvalho, C. M., Gannon, B. W., Halfhide, D. E., Santos, S. B., Hayes, C. M., Roe, J. M., & Azeredo, J. (2010) · BMC Microbiology · doi:10.1186/1471-2180-10-232 · Cited by 223
Chan, B. K., & Abedon, S. T. (2012) · Advances in Applied Microbiology · doi:10.1016/b978-0-12-394805-2.00001-4 · Cited by 212
Rapid diversification of coevolving marine Synechococcus and a virus
Marston, M. F., Pierciey, F. J., Shepard, A., Gearin, G., Qi, J., Yandava, C., Schuster, S. C., Henn, M. R., & Martiny, J. B. H. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120310109 · Cited by 204
Filippov, A. A., Sergueev, K. V., He, Y., Huang, X.-Z., Gnade, B. T., Mueller, A. J., Fernandez-Prada, C. M., & Nikolich, M. P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025486 · Cited by 191
Regeimbal, J. M., Jacobs, A. C., Corey, B. W., Henry, M. S., Thompson, M. G., Pavlicek, R. L., Quinones, J., Hannah, R. M., Ghebremedhin, M., Crane, N. J., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02877-15 · Cited by 187
Oral Application of T4 Phage Induces Weak Antibody Production in the Gut and in the Blood
Majewska, J., Beta, W., Lecion, D., Hodyra-Stefaniak, K., Kłopot, A., Kaźmierczak, Z., Miernikiewicz, P., Piotrowicz, A., Ciekot, J., Owczarek, B., et al. (2015) · Viruses · doi:10.3390/v7082845 · Cited by 186
Coevolution of Bacteriophage PP01 and Escherichia coli O157:H7 in Continuous Culture
Mizoguchi, K., Morita, M., Fischer, C. R., Yoichi, M., Tanji, Y., & Unno, H. (2003) · Applied and Environmental Microbiology · doi:10.1128/aem.69.1.170-176.2003 · Cited by 184
Enhancement of host fitness by the sul2-coding plasmid p9123 in the absence of selective pressure
Enne, V. I. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh217 · Cited by 171
Torres-Barceló, C., Arias-Sánchez, F. I., Vasse, M., Ramsayer, J., Kaltz, O., & Hochberg, M. E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106628 · Cited by 166
Hung, C., Kuo, C.-F., Wang, C.-H., Wu, C.-M., & Tsao, N. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01123-10 · Cited by 165
Totté, J. E. E., van Doorn, M. B., & Pasmans, S. G. M. A. (2017) · Case Reports in Dermatology · doi:10.1159/000473872 · Cited by 161
Seed, K. D., Faruque, S. M., Mekalanos, J. J., Calderwood, S. B., Qadri, F., & Camilli, A. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002917 · Cited by 159
Górski, A., Międzybrodzki, R., Weber‐Dąbrowska, B., Fortuna, W., Letkiewicz, S., Rogóż, P., Jończyk‐Matysiak, E., Dąbrowska, K., Majewska, J., & Borysowski, J. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01515 · Cited by 156
Costs of CRISPR-Cas-mediated resistance inStreptococcus thermophilus
Vale, P. F., Lafforgue, G., Gatchitch, F., Gardan, R., Moineau, S., & Gandon, S. (2015) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.2015.1270 · Cited by 149
Pouillot, F., Chomton, M., Blois, H., Courroux, C., Noelig, J., Bidet, P., Bingen, É., & Bonacorsi, S. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06330-11 · Cited by 145
Evolutionary consequences of intra-patient phage predation on microbial populations
Seed, K. D., Yen, M., Shapiro, B. J., Hilaire, I. J., Charles, R. C., Teng, J. E., Ivers, L. C., Boncy, J., Harris, J. B., & Camilli, A. (2014) · eLife · doi:10.7554/elife.03497 · Cited by 142
Destoumieux‐Garzón, D., Duquesne, S., Péduzzi, J., Goulard, C., Desmadril, M., Letellìer, L., Rebuffat, S., & Boulanger, P. (2005) · Biochemical Journal · doi:10.1042/bj20042107 · Cited by 140
Is there a cost of virus resistance in marine cyanobacteria?
Lennon, J. T., Khatana, S. A. M., Marston, M. F., & Martiny, J. B. H. (2007) · The ISME Journal · doi:10.1038/ismej.2007.37 · Cited by 140
Phage Therapy in a 16-Year-Old Boy with Netherton Syndrome
Zhvania, P., Hoyle, N. S., Nadareishvili, L., Nizharadze, D., & Kutateladze, M. (2017) · Frontiers in Medicine · doi:10.3389/fmed.2017.00094 · Cited by 140
Phage therapy: awakening a sleeping giant
Roach, D. R., & Debarbieux, L. (2017) · Emerging Topics in Life Sciences · doi:10.1042/etls20170002 · Cited by 128
Bacteria‐Phage Coevolution and the Emergence of Generalist Pathogens
Hall, A. R., Scanlan, P. D., & Buckling, A. (2010) · The American Naturalist · doi:10.1086/657441 · Cited by 126
Seed, K. D., Bodi, K. L., Kropinski, A. M., Ackermann, H., Calderwood, S. B., Qadri, F., & Camilli, A. (2011) · mBio · doi:10.1128/mbio.00334-10 · Cited by 122
Kirby, A. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051017 · Cited by 120
Bacteriophage Therapy ofSalmonella enterica:A Fresh Appraisal of Bacteriophage Therapy
Capparelli, R., Nocerino, N., Iannaccone, M., Ercolini, D., Parlato, M., Medaglia, C., & Iannelli, D. (2009) · The Journal of Infectious Diseases · doi:10.1086/648478 · Cited by 120
Verma, V., Harjai, K., & Chhibber, S. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp360 · Cited by 120
Molecular Basis for Lytic Bacteriophage Resistance in Enterococci
Duerkop, B. A., Huo, W., Bhardwaj, P., Palmer, K. L., & Hooper, L. V. (2016) · mBio · doi:10.1128/mbio.01304-16 · Cited by 112
Sørensen, M. C. H., van Alphen, L. B., Fodor, C., et al. (2012) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2012.00011 · Cited by 108
SKLAR, I. B., & Joerger, R. D. (2001) · Journal of Food Safety · doi:10.1111/j.1745-4565.2001.tb00305.x · Cited by 108
Antagonistic coevolution with parasites increases the cost of host deleterious mutations
Buckling, A. G. J., Wei, Y., Massey, R. C., Brockhurst, M. A., & Hochberg, M. (2005) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.2005.3279 · Cited by 107
Capparelli, R., Nocerino, N., Lanzetta, R., Silipo, A., Amoresano, A., Giangrande, C., Becker, K., Blaiotta, G., Evidente, A., Cimmino, A., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011720 · Cited by 105
Evidence that TraT interacts with OmpA of Escherichia coli
Riede, I., & Eschbach, M.-L. (1986) · FEBS Letters · doi:10.1016/0014-5793(86)80905-x · Cited by 101
Capsular Polysaccharides and Their Role in Virulence
Taylor, C. M., & Roberts, I. S. (2004) · Contributions to microbiology · doi:10.1159/000081689 · Cited by 99
Maura, D., Morello, E., du Merle, L., Bomme, P., Bouguénec, C. L., & Debarbieux, L. (2011) · Environmental Microbiology · doi:10.1111/j.1462-2920.2011.02644.x · Cited by 99
Effects of predation on real‐time host–parasite coevolutionary dynamics
Friman, V., & Buckling, A. (2012) · Ecology Letters · doi:10.1111/ele.12010 · Cited by 96
Effect of Phage on the Infectivity of Vibrio cholerae and Emergence of Genetic Variants
Zahid, M. S. H., Udden, S. M. N., Faruque, A. S. G., Calderwood, S. B., Mekalanos, J. J., & Faruque, S. M. (2008) · Infection and Immunity · doi:10.1128/iai.00578-08 · Cited by 77
Population mixing promotes arms race host–parasite coevolution
Gómez, P., Ashby, B., & Buckling, A. (2014) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.2014.2297 · Cited by 72
What Can Phages Tell Us about Host-Pathogen Coevolution?
Dennehy, J. J. (2012) · International Journal of Evolutionary Biology · doi:10.1155/2012/396165 · Cited by 70
Allen, R. C., Pfrunder‐Cardozo, K. R., Meinel, D. M., Egli, A., & Hall, A. R. (2017) · mBio · doi:10.1128/mbio.01341-17 · Cited by 51
Sublethal streptomycin concentrations and lytic bacteriophage together promote resistance evolution
Cairns, J., Becks, L., Jalasvuori, M., & Hiltunen, T. (2016) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2016.0040 · Cited by 47
Identification of Four Phage Resistance Plasmids from Lactococcus lactis subsp. cremoris HO2
Forde, A., Daly, C., & Fitzgerald, G. F. (1999) · Applied and Environmental Microbiology · doi:10.1128/aem.65.4.1540-1547.1999 · Cited by 43
EFFECTS OF TEMPERATURE ON THE FITNESS COST OF RESISTANCE TO BACTERIOPHAGE T4 INESCHERICHIA COLI.
Quance, M. A., & Travisano, M. (2009) · Evolution · doi:10.1111/j.1558-5646.2009.00654.x · Cited by 38
Friman, V., & Buckling, A. (2014) · The ISME Journal · doi:10.1038/ismej.2014.40 · Cited by 38
Co-adaptation of Escherichia coli and Coliphage vir in Continuous Culture
Spanakis, E., & Horne, M. T. (1987) · Microbiology · doi:10.1099/00221287-133-2-353 · Cited by 36
Isolation and characterization of bacteriophage-resistant mutants of Vibrio cholerae O139
Attridge, S. R., Fazeli, A., Manning, P. A., & Stroeher, U. H. (2001) · Microbial Pathogenesis · doi:10.1006/mpat.2000.0426 · Cited by 29
Cited by
Bacteriophage-resistant Acinetobacter baumannii are resensitized to antimicrobials
Gordillo Altamirano, F., Forsyth, J. H., Patwa, R., Kostoulias, X., Trim, M., Subedi, D., Archer, S. K., Morris, F. C., Oliveira, C., Kielty, L., et al. (2021) · Nature Microbiology · doi:10.1038/s41564-020-00830-7 · Cited by 349
Current challenges and future opportunities of phage therapy
Pires, D. P., Costa, A. R., Pinto, G., Meneses, L., & Azeredo, J. (2020) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuaa017 · Cited by 340
Engineered phage with antibacterial CRISPR–Cas selectively reduce E. coli burden in mice
Gencay, Y. E., Jasinskytė, D., Robert, C., Semsey, S., Martínez, V., Petersen, A. Ø., Brunner, K., de Santiago Torio, A., Salazar, A., Turcu, I. C., et al. (2024) · Nature Biotechnology · doi:10.1038/s41587-023-01759-y · Cited by 282
Alternative therapeutic strategies to treat antibiotic-resistant pathogens
MacNair, C. R., Rutherford, S. T., & Tan, M.-W. (2024) · Nature Reviews Microbiology · doi:10.1038/s41579-023-00993-0 · Cited by 276
Phage Therapy in the Resistance Era: Where Do We Stand and Where Are We Going?
Luong, T., Salabarria, A.-C., & Roach, D. R. (2020) · Clinical Therapeutics · doi:10.1016/j.clinthera.2020.07.014 · Cited by 266
Metadata
- Authors
- Oechslin, F.
- Venue
- Viruses
- Publisher
- MDPI AG
- Published
- 2018-06-30
- Volume
- 10
- Issue
- 7
- Pages
- 351
- ISSN
- 1999-4915 (ISSN-L)
- OpenAlex
- W2811180668
- Cited by
- 594
- References
- 96
- FWCI
- 30.24
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.